Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Grants
Scholarly Output
Datasets
Activities
Prizes
Search by expertise, name or affiliation
End-stage renal disease in patients with rheumatoid arthritis
Sunita Paudyal
, Frances M. Yang
, Christopher Rice
, Chen Chun Chen
, Michael Skelton
, Monique Bethel
,
Shilpa Brown
, Norris Stanley Nahman
,
Laura Carbone
Epidemiology
General Internal Medicine
Nephrology
Rheumatology
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'End-stage renal disease in patients with rheumatoid arthritis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Rheumatoid Arthritis
100%
End-stage Renal Disease
100%
United States Renal Data System (USRDS)
23%
Disease-modifying Antirheumatic Drugs (DMARDs)
23%
Hypertension
15%
Diabetes
15%
Prednisone
15%
Hydroxychloroquine
15%
Rheumatoid Arthritis Patients
15%
Treatment Strategy
7%
Etiology
7%
Comorbidity
7%
Amyloidosis
7%
Vasculitis
7%
Epidemiology
7%
Etanercept
7%
Critical Impact
7%
Rheumatoid Arthritis Treatment
7%
Race Categories
7%
Prednisolone
7%
Adalimumab
7%
Infliximab
7%
Abatacept
7%
Age Categories
7%
BMI Classification
7%
Non-rheumatoid
7%
Analgesic Nephropathy
7%
Anakinra
7%
Golimumab
7%
Medicine and Dentistry
Rheumatoid Arthritis
100%
End Stage Renal Disease
100%
Diabetes
12%
Biological Product
12%
Prednisone
12%
Hydroxychloroquine
12%
Disease-Modifying Antirheumatic Drug
12%
Drug Therapy
6%
Prevalence
6%
Cohort Effect
6%
Prospective Study
6%
Body Mass Index
6%
Cross Sectional Study
6%
Vasculitis
6%
Etanercept
6%
Abatacept
6%
Amyloidosis
6%
Prednisolone
6%
Adalimumab
6%
Infliximab
6%
Anakinra
6%
Analgesic Nephropathy
6%
Golimumab
6%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
End Stage Renal Disease
100%
Prednisone
12%
Biological Product
12%
Hydroxychloroquine
12%
Prospective Study
6%
Cross-Sectional Study
6%
Prevalence
6%
Amyloidosis
6%
Comorbidity
6%
Vasculitis
6%
Etanercept
6%
Abatacept
6%
Adalimumab
6%
Infliximab
6%
Prednisolone
6%
Anakinra
6%
Golimumab
6%
Analgesic Nephropathy
6%